Details for Patent: 8,528,545
✉ Email this page to a colleague
Which drugs does patent 8,528,545 protect, and when does it expire?
Patent 8,528,545 protects SYMBICORT and is included in one NDA.
Protection for SYMBICORT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-one patent family members in twenty-eight countries.
Summary for Patent: 8,528,545
| Title: | Inhaler device that reduces the risk for miscounting a dosage |
| Abstract: | Inhaler device (10) comprising an actuator body (20) and an inhaler canister assembly (70), the inhaler canister assembly (70) is comprised of a canister (30) with a metering valve at a valve end and a dose counter unit (60) attached to a base end thereof. Further, the inhaler canister assembly (70) comprises first position ensuring means (110, 230), the actuator body comprises second position ensuring means (120,210), wherein the first and second position ensuring means being complementary mating means, and the first and second position ensuring means being so arranged that the inhaler device (10) cannot be fired, nor the counter unit (60) count unless the first and second position ensuring means are in a mating relationship. There is also provided an inhaler canister assembly (70) and an actuator body (20). |
| Inventor(s): | Hodson; Darren (Leicestershire, GB), Treneman; William (Cambridgeshire, GB) |
| Assignee: | AstraZeneca AB (Sodertaije, SE) |
| Application Number: | 11/571,645 |
|
Patent Claim Types: see list of patent claims | Delivery; Device; Use; |
Drugs Protected by US Patent 8,528,545
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-001 | Jul 21, 2006 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-002 | Jul 21, 2006 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,528,545
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Sweden | 0401786 | Jul 05, 2004 |
| Sweden | 0401786 | Jul 5, 2004 |
| PCT Information | |||
| PCT Filed | June 23, 2005 | PCT Application Number: | PCT/SE2005/000996 |
| PCT Publication Date: | January 12, 2006 | PCT Publication Number: | WO2006/004498 |
International Family Members for US Patent 8,528,545
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 054295 | ⤷ Try a Trial | |||
| Argentina | 054296 | ⤷ Try a Trial | |||
| Austria | E411069 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
